Evidence map›Paper›PMID 42109863›Full record

ArticleResearch and practice in thrombosis and haemostasis2026

The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital.

Mazdak Tavoly, Camilla Tøvik Jørgensen, Katarina Glise Sandblad, Waleed Ghanima, Lamya Garabet

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mazdak TavolyDepartment of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Sahlgrenska, Region Västra Götaland, Gothenburg, Sweden.
Camilla Tøvik JørgensenDepartment of Emergency Medicine, Østfold Hospital, Norway.
Katarina Glise SandbladDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Waleed GhanimaDepartment of Research, Østfold Hospital, Sarpsborg, Norway.
Lamya GarabetCenter for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It has been suggested that D-dimer testing should be avoided in patients with prolonged symptoms, as results may yield false negatives. However, the evidence supporting this recommendation is limited. Objectives: This study evaluated the impact of symptom duration on D-dimer and investigated associations between false-negative D-dimer results and prolonged symptoms. Methods: Patients diagnosed with pulmonary embolism, deep vein thrombosis (DVT), or upper extremity DVT between 2005 and 2020 were identified through the Venous Thrombosis Registry in Results: In total 3423 patients were included, of whom 1696 (49.5%) were women, with a median age of 67 years (IQR, 54-78 years). The median symptom duration was 4 days (IQR, 2-10 days), and 946 patients (27.6%) reported symptoms exceeding 1 week. D-dimer showed a weak negative correlation with symptom duration (Kendall τ coefficient = -0.04; Conclusion: Although D-dimer were negatively correlated with symptom duration, the coefficient was very weak and unlikely to have clinical relevance. Moreover, false-negative D-dimer results were not associated with prolonged symptoms, suggesting that extended symptom duration may not affect the performance of D-dimer testing in clinical practice.

Indexed as

Fibrin Fibrinogen Degradation ProductsPulmonary EmbolismVenous ThrombosisAgedBiomarkersFalse Negative ReactionsFemaleHumansMaleMiddle AgedNorwayRegistriesTime FactorsBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment Dclinical laboratory servicesfibrinogenpulmonary embolismregistriesvenous thromboembolism

Identifiers

PMID42109863
PMCPMC13156636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.